Skip to main content

Table 3 Correlations between the TyG index and risk factors of HOCM

From: The triglyceride-glucose index as a potential protective factor for hypertrophic obstructive cardiomyopathy without diabetes: evidence from a two-center study

Variables

Invasive treatment group

Non-invasive treatment group

Correlation coefficient (r)

p-value

Correlation coefficient (r)

p-value

LV outflow tract gradient, at rest (mmHg)

− 0.072

0.483

− 0.099

0.521

LV ejection fraction (%)

− 0.220

0.031

0.072

0.644

Interventricular septal thickness (mm)

− 0.208

0.042

− 0.127

0.411

LV end-diastolic diameter (mm)

0.262

0.010

0.377

0.012

LV posterior wall thickness (mm)

0.073

0.478

− 0.096

0.534

Systolic BP (mmHg)

0.114

0.267

− 0.098

0.528

Diastolic BP (mmHg)

0.105

0.308

− 0.028

0.858

Heart Rate (bpm)

− 0.024

0.820

− 0.081

0.599

NYHA Class III or IV, n (%)

− 0.038

0.710

− 0.064

0.678

Atrial fibrillation, n (%)

− 0.015

0.885

− 0.015

0.920

LDL-C (mmol/L)

− 0.014

0.895

0.400

0.007

HDL-C(mmol/L)

− 0.425

 < 0.001

− 0.382

0.010

Cr (µmol/L)

0.250

0.014

0.207

0.177

h-CRP(mg/L)

0.227

0.026

0.100

0.518

NT-proBNP (fmol/mL)

− 0.224

0.028

− 0.224

0.028

Age

0.099

0.033

− 0.028

0.661

BMI

0.336

 < 0.001

0.168

0.271

  1. TyG index triglyceride-glucose index, BMI body mass index, LVEF left ventricle ejection fraction, LDL-C low-density lipoprotein-cholesterol, HDL-C high-density lipoprotein-cholesterol
  2. p-values in bold are < 0.05